Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

View:
Post by Alex1726 on May 25, 2023 5:26pm

$

Now we have an explanation why AV PILL and the scale up has been delayed without explanation, as i already mentionned if cash is not miising now it could in a near futur espicially with a Phase 1 cilival trial for fibrosis.

Also there is  information leak in this company , before they released the Q4 results we've seen the share price going down and the daily volume increased , same thing happened in recent weeks, but that could employees in the work shop. In a regular business some heads would start to fall like our new star Sigrun. This a poor management team and that explains why the majority never buy shares.
Comment by prophetoffactz on May 25, 2023 6:12pm
Will they spin the fibrosis opportunity off into a seperate company? Avalyn raised C$80 million going into its Phase I clinical trial. Is the go/no go clinical trial decision in the summer potentially tied to spinning off the fibrosis drug into its own company? Maybe the government will provide funding for an accelerated COVID clinical trial. "In pursuing our objective to successfully ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities